A low-cost fluoropolymer capillary film platform with unique optical transparency and facilitates rapid and fully quantitative multiplex immunoassays
CFT has developed FluorEx™, a low-cost microfluidic fluoropolymer film that possesses unique optical transparency. The parallel array of 10 x 200 micron capillaries that allow rapid fully quantitative immunoassays to be incorporated in existing or emergent diagnostic technologies for use in the point of care clinical diagnostics market. CFT has exclusive know-how and IP. CFT’s FluorEx™ technology is available for licensing
CFT are delighted to have recently been featured on the BBC technology programme, ‘Click’. The programme was a medical special focussing on the latest developments in personalised medicine and included CFT’s low-cost microfluidic fluoropolymer capillary film. This product has unique fluidic and optical properties which facilitate rapid, quantitative, multiplexed immunoassays for clinical applications, such as cardiovascular diagnostics. The programme demonstrated how CFT’s fluoropolymer film, when used in conjunction with a smart phone camera, make it ideal for rapid biomarker measurements and accurate diagnostics. Read more
Capillary Film Technology Limited (CFT), a UK based technology and product development company for life sciences and clinical diagnostics, today announced it has received £1 million in funding through a Phase 2 Small Business Research Initiative for Healthcare (SBRI Healthcare) development contract. Read more
